$USNA

USANA HEALTH SCIENCES INC

CIK:0000896264|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 04, 2026	Jun. 28, 2025	Jul. 04, 2026	Jun. 28, 2025
Income Statement [Abstract]
Net sales	$ 223,273	$ 235,848	$ 473,491	$ 485,387
Cost of sales	48,339	50,184	107,775	102,629
Gross profit	174,934	185,664	365,716	382,758
Operating expenses:
Brand Partner incentives	83,475	87,040	172,129	177,025
Selling, general and administrative	82,318	81,906	170,572	173,344
Goodwill impairment	29,137	0	29,137	0
Total operating expenses	194,930	168,946	371,838	350,369
(Loss) earnings from operations	(19,996)	16,718	(6,122)	32,389
Other income (expense):
Interest income	595	619	1,032	1,342
Interest expense	0	(259)	(240)	(670)
Other, net	501	1,739	1,895	2,495
Other income (expense), net	1,096	2,099	2,687	3,167
(Loss) earnings before income taxes	(18,900)	18,817	(3,435)	35,556
Income taxes	9,051	8,373	17,557	15,822
Net (loss) earnings	(27,951)	10,444	(20,992)	19,734
Net (loss) earnings attributable to redeemable noncontrolling interest	(6,569)	789	(7,125)	677
Net (loss) earnings attributable to USANA	$ (21,382)	$ 9,655	$ (13,867)	$ 19,057
(Loss) earnings per common share attributable to USANA
Basic (in dollars per share)	$ (1.16)	$ 0.52	$ (0.75)	$ 1.01
Diluted (in dollars per share)	$ (1.16)	$ 0.52	$ (0.75)	$ 1.01
Weighted average common shares outstanding
Basic (in shares)	18,486	18,513	18,442	18,781
Diluted (in shares)	18,486	18,536	18,442	18,811
Comprehensive income (loss):
Net (loss) earnings	$ (27,951)	$ 10,444	$ (20,992)	$ 19,734
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	1,368	3,673	3,246	3,798
Tax (expense) benefit related to foreign currency translation adjustment	(608)	(270)	(744)	(477)
Other comprehensive income (loss), net of tax	760	3,403	2,502	3,321
Comprehensive income (loss)	(27,191)	13,847	(18,490)	23,055
Comprehensive (loss) income attributable to redeemable noncontrolling interest	(6,569)	789	(7,125)	677
Comprehensive (loss) income attributable to USANA	$ (20,622)	$ 13,058	$ (11,365)	$ 22,378

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jul. 04, 2026	Jun. 28, 2025
Cash flows from operating activities
Net (loss) earnings	$ (20,992)	$ 19,734
Adjustments to reconcile net (loss) earnings to net cash provided by (used in) operating activities
Depreciation and amortization	15,951	16,082
Right-of-use asset reduction	3,008	3,767
Loss on sale of property and equipment	26	29
Equity-based compensation expense	6,858	6,502
Deferred income taxes	(3,224)	(6,485)
Inventory write-down	3,069	2,045
Goodwill impairment	29,137	0
Changes in operating assets and liabilities:
Trade accounts receivable	959	1,729
Inventories	9,421	(12,988)
Prepaid expenses and other assets	715	(2,189)
Accounts payable	(1,860)	5,813
Other liabilities	(9,990)	(6,339)
Net cash provided by (used in) operating activities	33,078	27,700
Cash flows from investing activities
Payments for the settlement of net investment hedges	(917)	0
Payments for net investment hedge	0	(1,072)
Proceeds from acquisition working capital adjustment	0	865
Proceeds from sale of property and equipment	63	0
Purchases of property and equipment	(5,800)	(7,830)
Net cash provided by (used in) investing activities	(6,654)	(8,037)
Cash flows from financing activities
Repurchase of common stock	0	(27,507)
Borrowings on line of credit	9,000	1,600
Payments on line of credit	(23,000)	(24,600)
Payments related to tax withholding for net-share settled equity awards	(2,291)	(2,191)
Distributions to redeemable noncontrolling interest	(1,376)	(379)
Net cash provided by (used in) financing activities	(17,667)	(53,077)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	1,511	3,032
Net increase (decrease) in cash, cash equivalents, and restricted cash	10,268	(30,382)
Cash, cash equivalents, and restricted cash at beginning of period	161,240	184,508
Cash, cash equivalents, and restricted cash at end of period	171,508	154,126
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
Cash and cash equivalents	168,560	151,338
Restricted cash included in other assets	2,948	2,788
Total cash, cash equivalents, and restricted cash	171,508	154,126
Cash paid during the period for:
Interest	473	662
Income taxes	22,930	25,302
Cash received during the period for:
Income tax refund	249	45
Non-cash investing and financing activities:
Right-of-use assets obtained in exchange for lease obligations	1,647	6,262
Accrued purchases of property and equipment	13	63
Accrued excise tax for repurchase of common stock	$ 0	$ 231

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jul. 04, 2026	Jan. 03, 2026
Current assets
Cash and cash equivalents	$ 168,560	$ 158,380
Trade accounts receivable (net of allowance of $92 and $137, respectively)	3,337	4,285
Inventories	86,343	102,608
Prepaid expenses and other current assets	22,826	23,132
Total current assets	281,066	288,405
Property and equipment, net	94,269	94,383
Goodwill	109,141	137,962
Intangible assets, net	124,615	133,151
Deferred tax assets	29,539	27,209
Other assets	64,580	61,805
Total assets	703,210	742,915
Current liabilities
Accounts payable	15,431	17,263
Line of credit	0	14,000
Other current liabilities	90,244	97,302
Total current liabilities	105,675	128,565
Deferred tax liabilities	4,662	4,892
Other long-term liabilities	21,900	23,186
Total liabilities	132,237	156,643
Redeemable noncontrolling interest	44,667	53,168
Stockholders' equity
Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 18,463 as of July 4, 2026 and 18,281 as of January 3, 2026	18	18
Additional paid-in capital	88,111	83,544
Retained earnings	451,853	465,720
Accumulated other comprehensive income (loss)	(13,676)	(16,178)
Total stockholders' equity attributable to USANA	526,306	533,104
Total liabilities, redeemable noncontrolling interest, and stockholders' equity	$ 703,210	$ 742,915